Abstract: Composite materials made of a citrate, a calcium carbonate-containing material and an association moiety which is associated with the citrate and the calcium carbonate-containing material are provided. The composite materials are typically particulate materials (e.g., powdery materials). Compositions and articles-of-manufacturing containing and/or configured for applying the composite materials are also provided, as well as their use in inducing blood coagulation and arresting hemorrhage, including internal and/or massive hemorrhage.

Abstract: A treatment assembly can have an inner layer having an inner surface and an outer surface and defining a plurality of openings extending therethrough. The treatment assembly can further comprise a plurality of plates, each plate being at least partially received within a respective opening of the plurality of openings of the inner layer. The treatment assembly can further comprise treatment circuitry comprising a cable having a plurality of electrical leads and a plurality of lead ends, each electrical lead being electrically connected to a respective lead end of the plurality of lead ends. A cover layer can be attached to the outer surface of the inner layer and overlie the plurality of lead ends of the cable. The plurality of lead ends can be in contact with respective plates of the plurality of plates to define a plurality of electrodes.

Abstract: A website building system (WBS) includes a layout database to store at least one layout having components and an associated layout signature. It also includes a unit to determine a component set signature for an incoming component set having an existing layout provided by a user, to compare the component set signature with at least one associated layout signature of at least one layout from the database to find a match and to replace the existing layout with one of a selected diverse alternative candidate layout from the database according the match. The layout signature and the component set signature represent a hierarchical composition of the semantic types of the components of the layout and of the incoming component set accordingly. A layout adapter and applier adapts content from the user supplied component set to the selected diverse alternative candidate layout.

Abstract: A network device includes one or more communication ports, a packet processing circuit and an activity evaluation circuit. The one or more communication ports are configured to communicate packets over a network. The packet processing circuit is configured to process the packets. The activity evaluation circuit is configured to generate a sequence of multiple evaluation times independently of the packets, and, for each evaluation time among at least some of the evaluation times in the sequence, for any packet that is processed by the packet processing circuit at the evaluation time, to identify a session to which the packet belongs and issue an increment event associated with the identified session.

Abstract: Methods, systems, and computer readable media for automated transcription model adaptation includes obtaining audio data from a plurality of audio files. The audio data is transcribed to produce at least one audio file transcription which represents a plurality of transcription alternatives for each audio file. Speech analytics are applied to each audio file transcription. A best transcription is selected from the plurality of transcription alternatives for each audio file. Statistics from the selected best transcription are calculated. An adapted model is created from the calculated statistics.

Abstract: A compressor unit including a screw compressor having a compressor housing that has a screw rotor chamber arranged in the compressor housing, two screw rotors that are arranged in the screw rotor chamber and are mounted on the compressor housing to be rotatable about a respective screw rotor axis, and at least one control slider, which is arranged in a slider channel of the compressor housing, is adjacent to both screw rotors and is movable in a direction of displacement parallel to the screw rotor axes and takes a form such that it affects the final volume and/or the initial volume, wherein there is provided on the screw compressor a compressor operational control unit that takes a form such that it performs a compressor operating function that assists at least one operation of the compressor unit.

Abstract: A response activity pattern may be ascertained from a set of computing devices obtained during a monitoring mode of operation. The monitoring mode of operation can be initiated when a user command is determined to be a new or unknown command. The response activity pattern may be used to generate a response profile indicating an activity to carry out using one or more user devices to perform a task associated with the user command. When an indication of a previously unknown user command to perform a task is received, the generated response profile can be used to perform the designed task by carrying out the activity using the one or more user device. In this way, the activity that should be carried out to perform the task can be learned based on the monitored user activity related to the one or more user devices.

Abstract: A securing method for securing a crane on the occurrence of an exceptional event, the crane including a control-command system connected to actuators of the crane and integrated within a processing unit of the crane, the processing unit connected to movement, load and safety sensors placed on elements of the crane and configured to deliver information from events representative of exceptional events, wherein the securing method includes establishing a list of exceptional events detectable by the movement, load and safety sensors, associating levels of severity to each exceptional event, evaluating the level of severity of a detected exceptional event based on corresponding event information, switching from a nominal operating mode to a secure operating mode by applying a safety instruction associated with a severity level for the detected exceptional event, and emitting an alert message informing of the occurrence of the exception event.

Abstract: The present invention is directed to the field of immunotherapy. Specifically, the invention provides compositions and methods for improved T cell modulation ex vivo and in vivo and for the treatment of cancer and other pathologies. More specifically, embodiments of the invention are directed to the use of soluble NTB-A polypeptides or agonists thereof for the treatment of cancer patients, for preventing and treating cytopenia in susceptible patients, and for the ex vivo preparation of improved cell compositions.

Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.

Abstract: Methods of treating acromegaly in a subject are described herein. Exemplary methods include orally administering to the subject at least once daily at least one dosage form comprising octreotide, wherein the octreotide in each dosage form is 20 mg, and wherein the administering occurs at least 1 hour before a meal or at least 2 hours after a meal.

Abstract: Methods to solve the problem of performing fusion of images acquired with two cameras with different type sensors, for example a visible (VIS) digital camera and an short wave infrared (SWIR) camera, include performing image space equalization on images acquired with the different type sensors before performing rectification and registration of such images in a fusion process.

Abstract: The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.

Abstract: The pharmaceutical compositions described herein include a suspension which comprises an admixture in solid form of a therapeutically effective amount of a therapeutic agent and at least one salt of a medium chain fatty acid and a hydrophobic medium, e.g. castor oil or glyceryl tricaprylate or a mixture thereof. The pharmaceutical compositions described herein contain medium chain fatty acid salts and are substantially free of alcohols. The pharmaceutical compositions may be encapsulated in a capsule. Methods of treating or preventing diseases by administering such compositions to affected subjects are also disclosed.

Abstract: A marking composition may include an aqueous carrier and thermochromic capsules. The thermochromic capsules may include a leuco dye, an activator, and a temperature regulator. The thermochromic capsules may have a volume average size effective to resist temperature-mediated discoloration at a temperature of at least up to 40° C. by dissipating heat. In some embodiments, the marking composition marks a substrate with a substantially erasable mark, for example, in response to frictional contact with an eraser.

Abstract: A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitator, powered by the battery, the vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule; (c) a power supply disposed within the housing and adapted to power the vibrating agitator; and (d) a controller adapted, in response to receipt of an activation input, to activate the vibrating agitator to operate in the first vibrating mode of operation at at least one predetermined time of day. The system and method may be used to treat an ailment of the gastrointestinal tract and/or to mitigate at least one symptom of jetlag in a subject travelling from an origin location to a destination location.

Abstract: Aspects of the technology described herein maintain the privacy of confidential information to be communicated to a user through a computing device. The technology keeps confidential information private by assessing the privacy context of the communication. The privacy context can be determined by determining a privacy level of the information to be communicated and the privacy level of the environment into which the information is to be communicated. The privacy context can be used to select an appropriate communication channel for the information. The privacy context can also be used to determine whether all available content is shared or just a portion of it.

Abstract: A system and a method for treatment of a disorder in a gastrointestinal tract of a subject, using a treatment protocol, the treatment protocol being based at least in part on data relating to other subjects and their responses to treatment with various treatment protocols.

Abstract: A cage assembly can have at least one enclosure. Each enclosure can have a floor defining a floor area having a major dimension and a cover having a bottom surface. A spacing between the bottom surface of the cover and the floor can define a cage height. At least one sidewall can extend between the floor and the cover. A ratio of the cage height to the major dimension of the floor area of each enclosure of the at least one enclosure can be at least 0.70.